Chapter 51: Effectiveness of NaProTECHNOLOGY Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Clinical Outcomes Effectiveness Comparison
Chapter 84: Role of FertilityCare Practitioner Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Protocol Teaching Clinical Outcomes
Chapter 3: NaProTECHNOLOGY and the New Humanism Mirkes R 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Teaching Protocol Clinical Outcomes
Chapter 50: Pregnancy Following Failed ART Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Clinical Outcomes Effectiveness Protocol
Chapter 10: Special Instructions and Applications Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Teaching Teaching Methodology
Chapter 82: Postoperative Care and Complications Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Technique Endometriosis Protocol
Chapter 61: Preconceptional Care and the CREIGHTON MODEL System Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Clinical Outcomes Protocol Clinical Outcomes
Chapter 42: Endometriosis and Effects on Fertility Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Laparoscopy Mechanisms Technique
"Chapter 1: Disturbing Trends in the Health Care of Women, Children and Families" Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Paradigm Reproductive Technology Patient Rights
Chapter 71: PEARS for Bowel Endometriosis: Surgical Techniques for the Gynecologist Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Technique Outcomes Laparoscopy
Chapter 25: Chronic Discharges and CrMS Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Protocol Clinical Outcomes Teaching
Chapter 79: Recurrence of Endometriosis after PEARS Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Clinical Outcomes Outcomes Recurrence
Chapter 26: Isomolecular Hormones vs Heteromolecular Artimones Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Protocol Clinical Outcomes Clinical Utility
Chapter 16: Measuring Effectiveness and Pregnancy Rates of the CrMS Stanford JB 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Effectiveness Clinical Outcomes Effectiveness
Chapter 39: Medical Risks of Infertility Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Endometriosis-Related Ovulatory Dysfunction Unexplained
Chapter 80: Chronic Pelvic Pain and Dysmenorrhea Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Dysmenorrhea Laparoscopy Technique
Chapter 37: Role of Compounding Pharmacist Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Protocol Supplementation Physiology
Chapter 33: Osteoporosis and Role of CrMS Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Ovulatory Disturbances Amenorrhea Bone Formation
Chapter 76: PEARS for the Fallopian Tubes: Distal Occlusions and Other Applications Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Endometriosis Technique Tubal
Chapter 30: Postpartum Depression: Evaluation and Treatment Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Depression Recovery Supplementation
Chapter 23: Differences Between Laboratories Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Progesterone Estrogen LH
Chapter 22: Disorders of Human Ovulation: Clinical Validation of the Sonographic Classification System Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Follicular Monitoring Ovarian Morphology Monitoring
Chapter 83: Family Physician's Experience Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Clinical Outcomes Effectiveness Protocol
Chapter 60: Lethal Congenital Anomalies: Prenatal Diagnosis and the Management of Pregnancy Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Follicular Monitoring Endometrial Assessment Cervical Mucus
Chapter 69: Laparoscopic Laser Lysis of Adhesions Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Technique Technique Barriers
Chapter 27: Cooperative Progesterone and Estrogen Replacement Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Protocol Clinical Outcomes Clinical Utility
Chapter 66: Selective Hysterosalpingography and Transcervical Catheterization of the Fallopian Tubes Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Protocol Clinical Outcomes Follicular Monitoring
Chapter 11: Case Management Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Teaching Methodology Clinical Utility
Chapter 28: Effects of Stress Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Amenorrhea Oligomenorrhea Ovulation
Chapter 44: Pelvic Adhesive Disease Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Tubal Factor Clinical Utility Follicular Monitoring
Chapter 49: Family Physician's Approach Hilgers TW et al. 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Clinical Outcomes Protocol Effectiveness
The Medical & Surgical Practice of NaProTechnology Protocol Clinical Outcomes Restorative Approach
Chapter 81: Preventing Pelvic Adhesions Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Barriers Technique Outcomes
Chapter 8: Charting Continuous Discharges Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Protocol Teaching Protocol
Chapter 57: Recurrent Spontaneous Abortion Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Etiology Workup Treatment
Chapter 54: Assessing Progesterone During Pregnancy Hilgers TW 2004 The Medical and Surgical Practice of NaProTECHNOLOGY Assays Supplementation Physiology
DIR Jahrbuch 2003 (Deutsches IVF-Register Annual Report 2003) Deutsches IVF-Register e.V. 2004 Deutsches IVF-Register Jahrbuch
Annual report (Jahrbuch) of the Deutsches IVF-Register (DIR) for treatment year 2003. DIR is the German national IVF/ICSI registry, founded 1982 — the oldest continuously operating ART registry. Volun...
Pregnancy during the use of levonorgestrel intrauterine system Backman T et al. 2004 American journal of obstetrics and gynecology
OBJECTIVES: This study was undertaken to evaluate the pregnancy rate with the levonorgestrel intrauterine system (LNG IUS) and to analyze the outcome of pregnancies with the LNG IUS in situ in regular...
Aromatase Inhibitors in Ovulation Induction. In: Aromatase: Update and New Roles in Reproductive Disease. Carr BR, Bulun SE (Eds) Mitwally MFM et al. 2004 Sem Reprod Med
Assisted reproductive technology surveillance--United States, 2001 Wright VC et al. 2004 Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002)
Wright VC(1), Schieve LA, Reynolds MA, Jeng G, Kissin D.
Methodologic and statistical approaches to studying human fertility and environmental exposure Tingen C et al. 2003
Open Access
Environmental Health Perspectives Although there has been growing concern about the effects of environmental exposures on human fertility, standard epidemiologic study designs may not collect sufficient data to identify subtle effects...
Fertility Awareness Research Methodology
Prospective pregnancy study designs for assessing reproductive and developmental toxicants Buck GM et al. 2003
Open Access
Environmental Health Perspectives The determinants of successful human reproduction and development may act as early as periconceptionally, underscoring the need to capture exposures during these critical windows when assessing potent...
Research Methodology Infertility Pregnancy
ACOG Committee Opinion. Use of progesterone to reduce preterm birth ACOG 2003 Obstetrics and Gynecology Preterm birth affects 12% of all births in the United States. Recent studies support the hypothesis that progesterone supplementation reduces preterm birth in a select group of women (ie, those with a...
Progesterone Prevention Pregnancy Applications ACOG Recommendations
Ovulation induction is not the same as superovulation: the effect of selective estrogen receptor modulators and aromatase inhibitors Tourgeman DE 2003 Fertility and Sterility Pharmacological Agents Ovarian Stimulation Ovulation Induction vs Superovulation
Comparison of the effects of letrozole and clomiphene citrate on ovarian follicles, endometrium, and hormone levels in the rat Kilic-Okman T et al. 2003 Fertility and Sterility OBJECTIVE: To compare the effects of letrozole and clomiphene citrate in the rat in terms of number of ovarian follicles; endometrial thickness; and serum levels of E2, FSH, LH, and T.
DESIGN: Contro...
Letrozole vs Clomiphene Rat Models Ovarian and Endometrial Effects
Ovulation induction in women with infertility: a new indication for aromatase inhibitors Bulun SE 2003 Fertility and Sterility The third-generation aromatase inhibitors were initially introduced to treat postmenopausal breast cancer. We now realize that many other potential indications for aromatase inhibitors exist, especial...
Aromatase Inhibitors Mechanism of Action Letrozole Applications
Classification and pharmacology of progestins Schindler AE et al. 2003 Maturitas Besides the natural progestin, progesterone, there are different classes of progestins, such as retroprogesterone (i.e. dydrogesterone), progesterone derivatives (i.e. medrogestone) 17alpha-hydroxypro...
Progestin Classification Progestin Pharmacology Progestin Types and Effects
Letrozole: ovulation or superovulation? Casper RF 2003 Fertility and sterility Letrozole Ovarian Stimulation Controlled Ovulation vs Superovulation
The Enigma of Chronic Pelvic Pain: Systematically Tracing the Cause Differential Diagnosis Chronic Pelvic Pain Systematic Assessment
Minimal surgery for the twisted ischaemic adnexa can preserve ovarian function Oelsner G et al. 2003 Human reproduction (Oxford, England)
BACKGROUND: Recently detorsion has replaced salpingo-oophorectomy as treatment for the twisted ischaemic adnexa. This paper asssess whether the ovary resumes normal function after preservation by deto...